Records View

To evaluate detoxification and body fat mass decrease effect and safety of Wellnessup® diet: 4-weeks, Clinical trial

Status : Approved
First Submitted Date : 2018/04/06     Registered Date : 2018/07/13     Last Updated Date : 2018/05/18    

  • Status : Approved
  • First Submitted Date : 2018/04/06
  • Registered Date : 2018/07/13
  • Last Updated Date : 2018/05/18
Background - CRIS Registration Number, Unique Protocol ID, Public/Brief Title, Scientific Title, Acronym, MFDS Regulated Study, IND/IDE Protocol, Registered at Other Registry, Name of Registry/Registration Number
1. Background
CRIS
Registration Number
KCT0003002
Unique Protocol ID CTCF2_2017_Wellnessup 
Public/Brief Title To evaluate detoxification and body fat mass decrease effect and safety of Wellnessup® diet: 4-weeks, Clinical trial 
Scientific Title To evaluate detoxification and body fat mass decrease effect and safety of Wellnessup® diet: 4-weeks, Clinical trial 
Acronym  
MFDS Regulated Study No
IND/IDE Protocol No
Registered
at Other Registry
No
Healthcare Benefit
Approval Status
Institutional Review Board Information - Clinical research ethics review consisting of approval status, approval number, approval date, committee information, and data monitoring committee.
2. Institutional Review Board/Ethics Committee
Board Approval Status Submitted approval 
Board Approval Number CUH-2017-11-009-003 
Approval Date 2017-12-14 
Institutional Review Board
Name
Chonbuk National University Hospital Institutional Review Board 
Institutional Review Board
Address
20, Geonji-ro, Deokjin-gu, Jeonju-si, Jeollabuk-do 
Institutional Review Board
Telephone
063-250-2154 
Data Monitoring Committee No  
Contact Details Information - Contact Details Information consisting of Contact Person for Principal Investigator / Scientific Queries, Contact Person for Public Queries, Name of Contact Person for Updating Information, Title, Email, Telephone, Cellular Phone, Affiliation, Address.
3. Contact Details
Contact Person for Principal Investigator / Scientific Queries
Name Soo Wan Chae 
Title Professor 
Telephone +82-63-259-3040 
Affiliation Jeonbuk National University Hospital 
Address 20, Geonji-ro, Deokjin-gu, Jeonju, Jeonbuk, Korea 
Contact Person for Public Queries
Name Woo Rim Kim 
Title Researcher 
Telephone +82-63-259-3052 
Affiliation Jeonbuk National University Hospital 
Address 20, Geonji-ro, Deokjin-gu, Jeonju, Jeonbuk, Korea 
Contact Person for Updating Information
Name Woo Rim Kim 
Title Researcher 
Telephone +82-63-259-3052 
Affiliation Jeonbuk National University Hospital 
Address 20, Geonji-ro, Deokjin-gu, Jeonju, Jeonbuk, Korea 
Status Information - Status Information consisting of Study Site, Overall Recruitment Status, Date of First Enrollment, Status of First Enrollment, Target Number of Participant, Primary Completion Date, Recruitment Status by Participating Study Site, Name of Study Site, Recruitment Status, Date of First Enrollment, Status of First Enrollemnt.
4. Status
Study Site Single
Overall Recruitment Status Active, not recruiting  
Date of First Enrollment 2018-01-09 Actual
Target Number of Participant 45
Primary Completion Date 2018-02-09 , Actual
Study Completion Date 2018-04-13 , Actual
Recruitment Status by Participating Study Site 1
Name of Study Jeonbuk National University Hospital 
Recruitment Status Active, not recruiting  
Date of First Enrollment 2018-01-09 ,
Source of Monetary / Material Support Information - Source of Monetary / Material Support Information consisting of Organization Name, Organization Type, Project ID.
5. Source of Monetary / Material Support
1. Source of Monetary/Material Support    
Organization Name Jeonbuk National University Hospital 
Organization Type Medical Institute  
Project ID  
Sponsor Organization Information - Sponsor Organization Information consisting of Organization Name, Organization Type.
6. Sponsor Organization
1. Sponsor Organization    
Organization Name Jeonbuk National University Hospital 
Organization Type Medical Institute  
Study Summary Information
7. Study Summary
Lay Summary
It compares the variation in the hair harmful element and body fat indicators shown in the 4 weeks Wellnessup diet among women whose weight has increased to that of calorie-adjusted healthy group and normal diet group.
- Primary aims: In women whose weight has increased than normal, according to intake Wellnessup diet for 4-weeks, the changes in the hair harmful elements are compared to changes in the intake of comparison diet.
- Secondary aims: In women whose weight has increased than normal, according to intake Wellnessup diet for 4-weeks,the changes antropometric (weight, body mass index, body fat mass/percent, lean body mass, hip & waist circumference, wais-hip circumference ratio), lipid profile(total cholestrol, triglyceride, LDL-cholesterol, HDL-cholesterol, Apo A1, Apo B), glucose profile(fasting blood sugar, fasting insulin, HbA1c, HOMA-IR), inflamamatory factors (hs-CRP, ESR), uric acid, Vitamin D, GGT, fatty liver, urine organic acid, WHOQOL (The World Health Organization Quality of Life assessment) are compared to changes in the intake of comparison diet.
Study Design Information - Study Design Information consisting of Study Type, Study Purpose, Phase, Intervention Model, Blinding/Masking, Blinded Subject, Allocation, Intervention Type, Intervention Description, Number of Arms, Arm Label, Target Number of Participant, Arm Type, Arm Description.
8. Study Design
Study Type Interventional Study 
Study Purpose Others (Evaluation of the effects of diet decoding and body fat reduction.)
Phase Not applicable 
Intervention Model Parallel    
Blinding/Masking Open 
Allocation RCT 
Intervention Type Others (Diet)  
Intervention Description
1. Wellnessup diet group: Consists of ingredients produced in smart farm. The diet consists of shakes, fruit juice, salads and snack such as nuts bar. It consists of a two-week cycle menu.
 - Eat the provided diet for 28 days
2. Calorie-adjusted healthy diet group: The dietary composition is the same as that of the Wellnessup diet group. However, materials were purchased from the market rather than from smart farms.
  - Eat the provided diet for 28 days
3. Normal diet group: Eat daily meals that have no calorie restriction for 29 days.
Number of Arms
Arm 1 Arm Label
Wellnessu diet group
Target Number of Participant 15
Arm Type Experimental  
Arm Description
Eat Wellnessup diet that are served four times a day (breakfast, lunch, dinner, snack) for 28 days.
Arm 2 Arm Label
Calorie-adjusted healthy diet group
Target Number of Participant 15
Arm Type Placebo comparator  
Arm Description
Eat Calorie-adjusted healthy diet that are served four times a day (breakfast, lunch, dinner, snack) for 28 days.
Arm 3 Arm Label
Normal diet group
Target Number of Participant 15
Arm Type Active comparator  
Arm Description
Eat daily meals that have no calorie restriction for 28 days.
Subject Eligibility Information
9. Subject Eligibility
Condition(s)/Problem(s) * (E00-E90)Endocrine, nutritional and metabolic diseases 
   (E66.9)Obesity, unspecified 
Rare Disease No
Inclusion
Criteria
Gender Female 
Age 19Year~49Year
Description
1) Women over 19 years old and under 49 years old at the time of screening.
2) A person with a BMI between 23.5 and 30 kg/m2 at the time of screening.
3) The person who has heard and fully understood the full explanation of this human factors testing, and has agreed to voluntarily decide to participate and comply with the cautions.
Exclusion Criteria
1) A person who has lost more than 10 percent of weight within three months of screening.
2) Who has taken a medication or a health function food product associated with detoxification or weight loss within one month of screening.
3) Severe clinical attention is given to acute or chronic cardiovascular system, endocrinology, immune system, respiratory system, cold blood meter, kidney and urinary system, musculoskeletal system, inflammatory disease, and others.
4) There are people with gastrointestinal conditions (such as Cronic's disease) who can be affected by the human body's applied test, and people with gastro-related operations (except for simple appendix protrusion subtractomization or hernia).
5) Those who overreact about the ingredients in the human diet.
6)Who has continuously administered antipsychotics within six months of screening
7) A suspected drug abuse or medical history
8) Who is constantly drinking alcohol that has exceeded 21 units/week or has a history of alcohol abuse
9) Who shows the following in a diagnostic examination medical examination
☞ Serum AST, ALT > three times of the reference range upper limit
☞ Serum creatinine > 2.0 mg/dL
10) Who has participated in other human body applications within two months of screening
11) Menopause (non-month-free for more than 12 months) or menopause (non-precision for more than three consecutive months) women.
12) A woman who is pregnant or is suckling or has plans to be pregnant during the duration of this human body application testing.
13) Women who became pregnant with pregnancy agreed not to use effective contraception (condoms, birth control masks, intrauterine contraception, or if a male partner underwent vasectomy) during the trial period.
14) A person who has determined that a tester is unsuitable for participating in human factors testing for reasons other than diagnostic testing medical examination results.
Healthy Volunteers Yes
Outcome Measure(s) Information - Outcome Measure(s) Information consisting of Type of Primary Outcome, Primary Outcome, Outcome, Timepoint, Secondary Outcome, Outcome, Timepoint.
10. Outcome Measure(s)
Type of Primary Outcome Efficacy 
Primary Outcome(s) 1 
Outcome
Analyzed harmfulness element of hair
Timepoint
0 week, 4 week
Secondary Outcome(s) 1 
Outcome
Antropometric(weight, body mass index, body fat mass, percent body fat, lean body mass, waist circumference, hip circumference and waist-hip circumference ratio.)
Timepoint
Screening, 0 week, 4 week
Secondary Outcome(s) 2 
Outcome
Lipid profile (Total cholesterol, Triglyceride, LDL-cholestrol, HDL- cholesterol, Apo A1, Apo B)
Timepoint
0 week, 4 week
Secondary Outcome(s) 3 
Outcome
Glucose profile (fasting blood glucose, fasting insulin, HbA1c, HOMA-IR)
Timepoint
0 week, 4 week
Secondary Outcome(s) 4 
Outcome
Inflammatory factors (hs-CRP, ESR)
Timepoint
0 week, 4 week
Secondary Outcome(s) 5 
Outcome
Uric acid
Timepoint
0 week, 4 week
Secondary Outcome(s) 6 
Outcome
Gamma-Glutamyl Transferase (GGT)
Timepoint
0 week, 4 week
Secondary Outcome(s) 7 
Outcome
Vitamin  D
Timepoint
0 week, 4 week
Secondary Outcome(s) 8 
Outcome
Fatty liver
Timepoint
0 week, 4 week
Secondary Outcome(s) 9 
Outcome
Urine Organic Acid Test (β-Hydroxybutyrate, Isocitrate, Methylmalonate, α-Ketoisocaprate, α-Hydroxybutyrate (AHB), 3,4-Dihydroxyphenylpropionate (DHPP), 8-Hydroxy-2-deoxyguanosine (8-OHdG))
Timepoint
0 week, 4 week
Secondary Outcome(s) 10 
Outcome
World Health Organization Quality of Life-BREF
Timepoint
0 week, 4 week
Secondary Outcome(s) 11 
Outcome
subjective/objective adverse event
Timepoint
4 week
Secondary Outcome(s) 12 
Outcome
Results of laboratory test
Timepoint
Screening, 4 week
Secondary Outcome(s) 13 
Outcome
Vital sign (systolic/diastolic blood pressure, pulse)
Timepoint
Screening. 0 week, 4 week
Study Results and Publication Information - Study Results and Publication Information consisting of Result Registered, Final Enrollment Number, Number of Publication, Publications, Results Upload, Date of Posting Results, Protocol URL or File Upload, Brief Summary.
11. Study Results and Publication
Result Registered No
Sharing of Study Data Information - Sharing of Study Data Information consisting of Sharing Statement, Time of Sharing, Way of Sharing.
12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)
Sharing Statement No  
G
N
I
D
A
O
L